Orbits Oncology

Orbits Oncology offers a deep learning solution to predict how cancer patients respond to therapies through advanced analysis of complex lab tumor models, called organoids. The platform uses lab organoid drug screening data and real-world patient data as inputs for our proprietary AI algorithms to build predictive patient models. The team has published proof-of-concept data for pancreatic cancer, and are developing a second model for rectal cancer.